Eur Respir J 2000; 15: 682-686
Copyright © ERS Journals Ltd 2000
Airway inflammation, airway responsiveness and cough before and after inhaled budesonide in patients with eosinophilic bronchitis
CE Brightling,
R Ward,
AJ Wardlaw,
and
ID Pavord
Eosinophilic bronchitis is a common cause of chronic cough, characterized by sputum eosinophilia similar to that seen in asthma, but unlike asthma the patients have no objective evidence of variable airflow obstruction or airway hyperresponsiveness. The reason for the different functional associations is unclear. The authors have tested the hypothesis that in eosinophilic bronchitis the inflammation is mainly localized in the upper airway. In an open study the authors measured the lower (provocative concentration causing a 20% fall in forced expiratory volume in one second (PC20)) and upper (PC25 MIF50) airway responsiveness to histamine, lower and upper airway inflammation using induced sputum and nasal lavage, in II patients with eosinophilic bronchitis. The authors assessed changes in these measures and in cough reflex sensitivity to capsaicin and cough severity after 400 microg of inhaled budesonide for 4 weeks. A nasal eosinophilia was present in only three patients with one having upper airway hyperresponsiveness. Following treatment with inhaled corticosteroids the geometric mean sputum eosinophil count decreased from 12.8% to 2.9% (mean difference 4.4-fold, 95% confidence interval (CI) 2.14-10.02), the mean +/- sem cough visual analogue score on a 100 mm scale decreased from 27.2 +/- 6.6 mm to 12.6 +/- 5.7 mm (mean difference 14.6, 95% CI 9.1-20.1) and the cough sensitivity assessed as the capsaicin concentration required to cause two coughs (C2) and five coughs (C5) improved (C2 mean difference 0.75 doubling concentrations, 95% CI 0.36-1.1; C5 mean difference 1.3 doubling concentration, 95% CI 0.6-2.1). There was a significant positive correlation between the fold change in sputum eosinophil count and doubling dose change in C5 after inhaled budesonide (r=0.61). It is concluded that upper airway inflammation is not prominent in eosinophilic bronchitis and that inhaled budesonide improves the sputum eosinophilia, cough severity and sensitivity suggesting a causal link between the inflammation and cough.
This article has been cited by other articles:

|
 |

|
 |
 
H. K. Reddel, D. R. Taylor, E. D. Bateman, L.-P. Boulet, H. A. Boushey, W. W. Busse, T. B. Casale, P. Chanez, P. L. Enright, P. G. Gibson, et al.
An Official American Thoracic Society/European Respiratory Society Statement: Asthma Control and Exacerbations: Standardizing Endpoints for Clinical Asthma Trials and Clinical Practice
Am. J. Respir. Crit. Care Med.,
July 1, 2009;
180(1):
59 - 99.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. Haldar, C. E. Brightling, B. Hargadon, S. Gupta, W. Monteiro, A. Sousa, R. P. Marshall, P. Bradding, R. H. Green, A. J. Wardlaw, et al.
Mepolizumab and Exacerbations of Refractory Eosinophilic Asthma
N. Engl. J. Med.,
March 5, 2009;
360(10):
973 - 984.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. Barber and D Fishwick
Chronic cough - occupational considerations
Chronic Respiratory Disease,
November 1, 2008;
5(4):
211 - 221.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
A. H. Morice, G. A. Fontana, M. G. Belvisi, S. S. Birring, K. F. Chung, P. V. Dicpinigaitis, J. A. Kastelik, L. P. McGarvey, J. A. Smith, M. Tatar, et al.
ERS guidelines on the assessment of cough
Eur. Respir. J.,
June 1, 2007;
29(6):
1256 - 1276.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A H Morice, L McGarvey, I Pavord, and on behalf of the British Thoracic Society Cough Gu
Recommendations for the management of cough in adults
Thorax,
September 1, 2006;
61(suppl_1):
i1 - i24.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B. J. Canning
Anatomy and Neurophysiology of the Cough Reflex: ACCP Evidence-Based Clinical Practice Guidelines
Chest,
January 1, 2006;
129(1_suppl):
33S - 47S.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. E. Brightling
Chronic Cough Due to Nonasthmatic Eosinophilic Bronchitis: ACCP Evidence-Based Clinical Practice Guidelines
Chest,
January 1, 2006;
129(1_suppl):
116S - 121S.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. V. Dicpinigaitis and R. V. Alva
Safety of Capsaicin Cough Challenge Testing
Chest,
July 1, 2005;
128(1):
196 - 202.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S S Birring, R B Patel, D Parker, S Mckenna, B Hargadon, W R Monteiro, J F Falconer Smith, and I D Pavord
Airway function and markers of airway inflammation in patients with treated hypothyroidism
Thorax,
March 1, 2005;
60(3):
249 - 253.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
I. D. Pavord
Chronic cough: a rational approach to investigation and management
Eur. Respir. J.,
February 1, 2005;
25(2):
213 - 215.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B. Prudon, S. S. Birring, D. D. Vara, A. P. Hall, J. P. Thompson, and I. D. Pavord
Cough and Glottic-Stop Reflex Sensitivity in Health and Disease
Chest,
February 1, 2005;
127(2):
550 - 557.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S.-W. Park, Y. M. Lee, A. S. Jang, J. H. Lee, Y. Hwangbo, D. J. Kim, and C.-S. Park
Development of Chronic Airway Obstruction in Patients With Eosinophilic Bronchitis: A Prospective Follow-up Study
Chest,
June 1, 2004;
125(6):
1998 - 2004.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. Kanazawa, S. Nomura, and J. Yoshikawa
Role of Microvascular Permeability on Physiologic Differences in Asthma and Eosinophilic Bronchitis
Am. J. Respir. Crit. Care Med.,
May 15, 2004;
169(10):
1125 - 1130.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S.S. Birring, C. Passant, R.B. Patel, B. Prudon, G.E. Murty, and I.D. Pavord
Chronic tonsillar enlargement and cough: preliminary evidence of a novel and treatable cause of chronic cough
Eur. Respir. J.,
February 1, 2004;
23(2):
199 - 201.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S S Birring, C E Brightling, F A Symon, S G Barlow, A J Wardlaw, and I D Pavord
Idiopathic chronic cough: association with organ specific autoimmune disease and bronchoalveolar lymphocytosis
Thorax,
December 1, 2003;
58(12):
1066 - 1070.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A H Morice and J A Kastelik
Cough * 1: Chronic cough in adults
Thorax,
October 1, 2003;
58(10):
901 - 907.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C E Brightling, F A Symon, S S Birring, P Bradding, A J Wardlaw, and I D Pavord
Comparison of airway immunopathology of eosinophilic bronchitis and asthma
Thorax,
June 1, 2003;
58(6):
528 - 532.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R.O. Crapo, R.L. Jensen, and F.E. Hargreave
Airway inflammation in COPD: physiological outcome measures and induced sputum
Eur. Respir. J.,
June 1, 2003;
21(41_suppl):
19S - 28s.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S S Birring, B Prudon, A J Carr, S J Singh, M D L Morgan, and I D Pavord
Development of a symptom specific health status measure for patients with chronic cough: Leicester Cough Questionnaire (LCQ)
Thorax,
April 1, 2003;
58(4):
339 - 343.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M Fujimura, H Ogawa, Y Nishizawa, and K Nishi
Comparison of atopic cough with cough variant asthma: is atopic cough a precursor of asthma?
Thorax,
January 1, 2003;
58(1):
14 - 18.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H Minoguchi, K Minoguchi, A Tanaka, H Matsuo, N Kihara, and M Adachi
Cough receptor sensitivity to capsaicin does not change after allergen bronchoprovocation in allergic asthma
Thorax,
January 1, 2003;
58(1):
19 - 22.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Leader of the Working Group:, I.D. Pavord, Members of the Working Group:, P.J. Sterk, F.E. Hargreave, J.C. Kips, M.D. Inman, R. Louis, M.M.M. Pizzichini, E.H. Bel, et al.
Clinical applications of assessment of airway inflammation using induced sputum
Eur. Respir. J.,
July 1, 2002;
20(37_suppl):
40S - 43s.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P G Gibson, M Fujimura, and A Niimi
Eosinophilic bronchitis: clinical manifestations and implications for treatment
Thorax,
February 1, 2002;
57(2):
178 - 182.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
N. Katayama, M. Fujimura, A. Ueda, T. Kita, M. Abo, H. Tachibana, S. Myou, and K. Kurashima
Effects of Carbocysteine on Antigen-Induced Increases in Cough Sensitivity and Bronchial Responsiveness in Guinea Pigs
J. Pharmacol. Exp. Ther.,
June 1, 2001;
297(3):
975 - 980.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
C. E. BRIGHTLING, R. WARD, G. WOLTMANN, P. BRADDING, J. R. SHELLER, R. DWORSKI, and I. D. PAVORD
Induced Sputum Inflammatory Mediator Concentrations in Eosinophilic Bronchitis and Asthma
Am. J. Respir. Crit. Care Med.,
September 1, 2000;
162(3):
878 - 882.
[Abstract]
[Full Text]
|
 |
|
Copyright © 2000 by the European Respiratory Society.
|